Jurij Stekar
- Molecular Biology
- Pathology and Forensic Medicine top 5%
- Oncology top 10%
- Public Health, Environmental and Occupational Health
- Organic Chemistry
- Topics
- Chemotherapy-induced organ toxicity mitigation (6 papers)PI3K/AKT/mTOR signaling in cancer (4 papers)Sulfur Compounds in Biology (4 papers)
- Partner nations
- GermanyJapanNetherlands
In The Last Decade
Jurij Stekar
25 papers receiving 924 citations
Peers
Comparison fields: 5 of 97
- Molecular Biology 400
- Pathology and Forensic Medicine 307
- Oncology 263
- Public Health, Environmental and Occupational Health 130
- Organic Chemistry 102
Countries citing papers authored by Jurij Stekar
This map shows the geographic impact of Jurij Stekar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jurij Stekar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jurij Stekar more than expected).
Fields of papers citing papers by Jurij Stekar
This network shows the impact of papers produced by Jurij Stekar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jurij Stekar. The network helps show where Jurij Stekar may publish in the future.
Co-authorship network of co-authors of Jurij Stekar
This figure shows the co-authorship network connecting the top 25 collaborators of Jurij Stekar. A scholar is included among the top collaborators of Jurij Stekar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jurij Stekar. Jurij Stekar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 119 | |
| 3 | 9 | |
| 4 | 4 | |
| 5 | 29 | |
| 6 | 27 | |
| 7 | 3 | |
| 8 | 2 | |
| 9 | Chloroacetaldehyde and its contribution to urotoxicity during treatment with cyclophosphamide or ifosfamide. An experimental study/short communication. | 14 |
| 10 | 92 | |
| 11 | 31 | |
| 12 | Pharmacokinetics and metabolism of sodium 2-mercaptoethanesulfonate in the rat. | 72 |
| 13 | 53 | |
| 14 | 95 | |
| 15 | 3 | |
| 16 | 28 | |
| 17 | Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamide. | 155 |
| 18 | 2 | |
| 19 | 1 | |
| 20 | 43 |
About Jurij Stekar
Jurij Stekar is a scholar working on Biochemistry, Pathology and Forensic Medicine and Hematology, having authored 25 papers that have together received 1.0k indexed citations. Recurring topics across this work include Chemotherapy-induced organ toxicity mitigation (6 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Sulfur Compounds in Biology (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (307 citations), Oncology (263 citations) and Biochemistry (65 citations). Jurij Stekar has collaborated with scholars based in Germany, Japan and Netherlands. Frequent co-authors include N Brock, Jörg Pohl, J. Pohl, W Scheef, Peter Hilgard, Bernhard Kutscher, Ulf Niemeyer, P. Hilgard, R. Voegeli and J. Engel. Their work appears in journals such as Cellular and Molecular Life Sciences, European Journal of Cancer and Cancer Treatment Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.